Cell Vault is the world's first t-cell bank, offering the opportunity for healthy individuals to preserve their most viable cells to combat cancer and other diseases in the future. With the FDA approval of CAR-T therapy in 2017, which utilizes a patient's own t-cells to cure blood cancers, there has been a surge in t-cell related clinical trials and investments. As the immune system weakens with age, preserving the healthiest t-cells now is crucial. The process begins with ordering a kit and scheduling a convenient in-home or in-office blood draw, after which the cells are securely stored to combat any potential future diseases.
Founded in 2019, Cell Vault operates in the Biotechnology, Health Care, and Life Sciences sectors. Although specific details about the headquarters, last investment, and investors are not available at the moment, the innovative concept and potential impact of Cell Vault in the rapidly evolving field of t-cell therapy make it a compelling prospect for further exploration and potential investment.
